{"id":"glucose-5-placebo","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Phlebitis (if administered intravenously)"},{"rate":null,"effect":"Fluid overload"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a 5% dextrose solution in water, this preparation provides osmotic and nutritional support but is used in clinical trials as a control arm to establish baseline efficacy and safety of an investigational agent. The solution has no specific molecular target or therapeutic mechanism beyond basic fluid and caloric supplementation.","oneSentence":"Glucose 5% solution serves as an inert placebo control with no active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:14:13.584Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Placebo control in phase 3 clinical trial (specific indication unknown)"}]},"trialDetails":[{"nctId":"NCT07493785","phase":"PHASE2, PHASE3","title":"Dexmedetomidine for Invasive Ventilation In the NEOnate","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2026-06-01","conditions":"Invasive Ventilation, Infant Pain, Infant Discomfort","enrollment":246},{"nctId":"NCT07224711","phase":"PHASE4","title":"The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2026-07-01","conditions":"Pain, Post Operative Analgesia, Opioid Consumption, Postoperative","enrollment":2290},{"nctId":"NCT07169851","phase":"PHASE2","title":"A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-11-28","conditions":"Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions","enrollment":204},{"nctId":"NCT06611111","phase":"EARLY_PHASE1","title":"Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease","status":"RECRUITING","sponsor":"State University of New York - Upstate Medical University","startDate":"2025-02-03","conditions":"Post-Treatment Lyme Disease","enrollment":44},{"nctId":"NCT05962606","phase":"PHASE2","title":"Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.","status":"COMPLETED","sponsor":"Aptarion Biotech AG","startDate":"2024-02-02","conditions":"Community-acquired Pneumonia","enrollment":150},{"nctId":"NCT02173756","phase":"PHASE3","title":"Evaluation of Oral Morphine Gel in Oral Mucositis Induced by Chemotherapy in Children and Young Adults","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","startDate":"2014-06","conditions":"Cancer","enrollment":25},{"nctId":"NCT03142568","phase":"PHASE2","title":"Safety of Sildenafil in Premature Infants","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2018-04-02","conditions":"Bronchopulmonary Dysplasia","enrollment":109},{"nctId":"NCT07118891","phase":"PHASE1, PHASE2","title":"Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause","status":"RECRUITING","sponsor":"AbCellera Biologics Inc.","startDate":"2025-06-23","conditions":"Vasomotor Symptoms Associated With Menopause, Healthy Volunteers","enrollment":136},{"nctId":"NCT04608630","phase":"PHASE2","title":"Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults","status":"RECRUITING","sponsor":"Australian and New Zealand Intensive Care Research Centre","startDate":"2021-07-15","conditions":"Critical Illness, Osteoporosis","enrollment":450},{"nctId":"NCT05304715","phase":"PHASE2","title":"Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2022-04-13","conditions":"Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome","enrollment":44},{"nctId":"NCT05832034","phase":"PHASE2, PHASE3","title":"Add-on Intravenous Immunoglobulins in Early Myositis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2021-09-13","conditions":"Inflammatory Myopathy, Idiopathic, Dermatomyositis, Antisynthetase Syndrome","enrollment":44},{"nctId":"NCT05125809","phase":"PHASE2, PHASE3","title":"Setrusumab vs Placebo for Osteogenesis Imperfecta","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ultragenyx Pharmaceutical Inc","startDate":"2022-02-21","conditions":"Osteogenesis Imperfecta","enrollment":183},{"nctId":"NCT05174507","phase":"PHASE2","title":"Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes","status":"WITHDRAWN","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-06-24","conditions":"Postprandial Hypoglycemia","enrollment":""},{"nctId":"NCT04918719","phase":"PHASE2","title":"Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2023-11-02","conditions":"Acute Ischemic Stroke","enrollment":4},{"nctId":"NCT07406477","phase":"PHASE2","title":"The PROTECT-HIE Trial","status":"NOT_YET_RECRUITING","sponsor":"University of Alberta","startDate":"2026-05-01","conditions":"Hypoxic-ischemic Encephalopathy (HIE)","enrollment":40},{"nctId":"NCT04094038","phase":"PHASE4","title":"The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2019-09-16","conditions":"End Stage Renal Disease, Malnutrition, Sarcopenia","enrollment":166},{"nctId":"NCT02642640","phase":"NA","title":"Interaction of Melatonin and MTNR1B Genotype on Glucose Control - Study 1","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2016-11","conditions":"Glucose, Circadian Rhythm, Melatonin","enrollment":23},{"nctId":"NCT06050577","phase":"PHASE2","title":"The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Odense University Hospital","startDate":"2024-06-07","conditions":"Type 2 Diabetes, Osteopenia","enrollment":64},{"nctId":"NCT07389837","phase":"NA","title":"Maple Syrup Carbohydrate Dose-Response on 20-km Cycling Time-Trial Performance","status":"NOT_YET_RECRUITING","sponsor":"Université de Montréal","startDate":"2026-02-01","conditions":"Exercise, Endurance Cycling Performance, Carbohydrate Intolerance","enrollment":32},{"nctId":"NCT03953677","phase":"PHASE3","title":"Evaluation of the Effect of Dexmedetomidine on Phenylephrine Response During Refractory Septic Shock","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2019-10-27","conditions":"Septic Shock, Vasopressor Resistance","enrollment":32},{"nctId":"NCT06532240","phase":"PHASE3","title":"Methylene Blue for the Treatment of Septic Shock","status":"COMPLETED","sponsor":"Northern Jiangsu People's Hospital","startDate":"2024-08-05","conditions":"Septic Shock","enrollment":88},{"nctId":"NCT03635567","phase":"PHASE3","title":"Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-10-25","conditions":"Cervical Cancer","enrollment":617},{"nctId":"NCT04158674","phase":"PHASE3","title":"Interest of Levosimendan in Reducing Weaning Failures of ExtraCorporeal Life Support - ECLS","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2020-02-24","conditions":"Acute Decompensated Heart Failure","enrollment":82},{"nctId":"NCT04666636","phase":"PHASE2","title":"Mechanisms for Activation of Beige Adipose Tissue in Humans","status":"RECRUITING","sponsor":"Philip Kern","startDate":"2020-12-07","conditions":"PreDiabetes","enrollment":65},{"nctId":"NCT06785402","phase":"PHASE1, PHASE2","title":"Ceftriaxone for Post-Treatment Lyme Disease","status":"RECRUITING","sponsor":"Hackensack Meridian Health","startDate":"2026-02-15","conditions":"Post-Treatment Lyme Disease Syndrome","enrollment":20},{"nctId":"NCT07356024","phase":"NA","title":"Effect of Acupressure on Blood Glucose And Anxiety in Elderly With Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Abant Izzet Baysal University","startDate":"2026-01-24","conditions":"Diabetes Mellitus, Acupressure","enrollment":48},{"nctId":"NCT07369284","phase":"PHASE2","title":"Melatonin for Glycemic Control in Gestational Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Obstetrics & Gynecology Hospital of Fudan University","startDate":"2026-02","conditions":"Gestational Diabetes","enrollment":150},{"nctId":"NCT04447989","phase":"PHASE2","title":"Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia","status":"COMPLETED","sponsor":"Christoph Hornik","startDate":"2021-05-27","conditions":"Bronchopulmonary Dysplasia of Newborn","enrollment":125},{"nctId":"NCT06151964","phase":"PHASE1, PHASE2","title":"A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2023-09-29","conditions":"Overweight and Obesity","enrollment":118},{"nctId":"NCT06305767","phase":"PHASE1, PHASE2","title":"A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-03-28","conditions":"Bladder Cancer","enrollment":230},{"nctId":"NCT07105202","phase":"PHASE4","title":"Shorter Weaning From Invasive Ventilation With Levosimendan","status":"RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2025-09-17","conditions":"Mechanical Ventilation, Weaning Failure","enrollment":250},{"nctId":"NCT06208215","phase":"PHASE3","title":"RZ358 Treatment for Congenital Hyperinsulinism","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rezolute","startDate":"2024-01-11","conditions":"Congenital Hyperinsulinism","enrollment":56},{"nctId":"NCT07318103","phase":"PHASE2","title":"Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention","status":"RECRUITING","sponsor":"Fujian Shengdi Pharmaceutical Co., Ltd.","startDate":"2025-12-31","conditions":"Fluid Retention Caused by Heart Failure","enrollment":118},{"nctId":"NCT07311330","phase":"PHASE2","title":"Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"Beijing Inno Medicine Co., Ltd.","startDate":"2026-01-31","conditions":"Atherosclerotic Cardiovascular Disease (ASCVD), Erectile Dysfunction","enrollment":40},{"nctId":"NCT04986072","phase":"PHASE2","title":"Sodium Nitroprusside in Early Course Schizophrenia","status":"TERMINATED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2022-03-14","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":1},{"nctId":"NCT06609356","phase":"EARLY_PHASE1","title":"Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2025-07-03","conditions":"Type 1 Diabetes Mellitus, Glucokinase-Maturity Onset Diabetes of the Young (GCK-MODY), MODY2 Diabetes","enrollment":27},{"nctId":"NCT05838573","phase":"PHASE3","title":"Metformin Treatment on Cognitive Impairment of Schizophrenia","status":"RECRUITING","sponsor":"Central South University","startDate":"2023-05-08","conditions":"Schizophrenia","enrollment":120},{"nctId":"NCT06433635","phase":"PHASE4","title":"Sequential Multiple Assignment Randomized Trial for Bipolar Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-10-01","conditions":"Bipolar I Disorder, Depression","enrollment":2726},{"nctId":"NCT03012360","phase":"PHASE4","title":"Antimicrobial Treatment in Patients With Ventilator-associated Tracheobronchitis","status":"TERMINATED","sponsor":"University Hospital, Lille","startDate":"2018-02-08","conditions":"Mechanical Ventilation Complication, Critical Illness","enrollment":103},{"nctId":"NCT07073781","phase":"NA","title":"Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation","status":"RECRUITING","sponsor":"Leeds Beckett University","startDate":"2025-08-15","conditions":"Impaired Glucose Regulation, Impaired Glucose Tolerance (Prediabetes), Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)","enrollment":70},{"nctId":"NCT03608033","phase":"PHASE3","title":"Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy","status":"TERMINATED","sponsor":"Omeros Corporation","startDate":"2018-04-05","conditions":"IgA Nephropathy","enrollment":360},{"nctId":"NCT07233382","phase":"NA","title":"Assessing the Efficacy of Probiotics in Prevention of NEC in Preterm Babies","status":"NOT_YET_RECRUITING","sponsor":"Hayatabad Medical Complex","startDate":"2025-12-01","conditions":"NEC, NEC - Necrotizing Enterocolitis","enrollment":196},{"nctId":"NCT03039673","phase":"PHASE2","title":"MIROCALS: Modifying Immune Response and OutComes in ALS","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2017-06-19","conditions":"Amyotrophic Lateral Sclerosis","enrollment":304},{"nctId":"NCT06547554","phase":"PHASE1","title":"A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants","status":"COMPLETED","sponsor":"Qpex Biopharma, Inc.","startDate":"2024-09-04","conditions":"Bacterial Infections","enrollment":60},{"nctId":"NCT06911359","phase":"PHASE2","title":"The Effect and Safety of Anti-inflammatories and Dextrose Prolotherapy Injections in Treating Knee Osteoarthritis","status":"RECRUITING","sponsor":"David Grant U.S. Air Force Medical Center","startDate":"2025-03-31","conditions":"Knee Osteoarthritis (OA)","enrollment":68},{"nctId":"NCT07239115","phase":"PHASE3","title":"Levetiracetam for Seizure Prevention After Brain Tumor Surgery","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-01","conditions":"Postoperative Seizures After Brain Tumor Surgery","enrollment":558},{"nctId":"NCT07229014","phase":"NA","title":"Effects of a Collagen Supplement on Quality of Life, Appetite and Glycaemic Control","status":"RECRUITING","sponsor":"King's College London","startDate":"2025-12","conditions":"Quality of Life, Appetite, Sleep","enrollment":100},{"nctId":"NCT02951130","phase":"PHASE2","title":"Milrinone in Congenital Diaphragmatic Hernia","status":"COMPLETED","sponsor":"NICHD Neonatal Research Network","startDate":"2017-10-24","conditions":"Congenital Diaphragmatic Hernia, Persistent Pulmonary Hypertension of the Newborn, Hypoxemic Respiratory Failure","enrollment":66},{"nctId":"NCT05684692","phase":"PHASE2","title":"Screening Trial for Pain Relief in Schwannomatosis (STARFISH)","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-08-31","conditions":"Schwannomatosis, Schwannomas, Pain, Chronic","enrollment":40},{"nctId":"NCT03036488","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2017-03-07","conditions":"Triple Negative Breast Neoplasms","enrollment":1174},{"nctId":"NCT03740165","phase":"PHASE3","title":"Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-12-18","conditions":"Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms","enrollment":1367},{"nctId":"NCT02367040","phase":"PHASE3","title":"Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-08-03","conditions":"Lymphoma,Non-Hodgkin","enrollment":458},{"nctId":"NCT04082533","phase":"PHASE4","title":"Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital for Special Surgery, New York","startDate":"2019-07-24","conditions":"Pain, Arthrofibrosis, Osteoarthritis, Knee","enrollment":132},{"nctId":"NCT02894710","phase":"PHASE3","title":"Intravenous Lidocaine in Carcinologic ENT Surgery: A Trial for Evaluation of Opioid Saving Strategy and Chronic Post-surgical Pain (ELICO)","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2016-12","conditions":"Carcinologic Ear, Nose, and Throat (ENT) Surgery","enrollment":143},{"nctId":"NCT03782636","phase":"PHASE2","title":"Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Oxford","startDate":"2019-01-28","conditions":"Type1 Diabetes","enrollment":41},{"nctId":"NCT07063095","phase":"PHASE3","title":"A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patients With Suspected Severe Gram-negative Bacterial Infections","status":"RECRUITING","sponsor":"Angela HUTTNER","startDate":"2025-08-25","conditions":"Gram Negative Infections, Sepsis and Septic Shock","enrollment":100},{"nctId":"NCT06964087","phase":"PHASE2","title":"Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Op-T LLC","startDate":"2025-05-27","conditions":"Type I Diabetes","enrollment":72},{"nctId":"NCT06251375","phase":"PHASE4","title":"Early Sedation With Dexmedetomidine vs. Placebo in Older Ventilated Critically Ill Patients","status":"NOT_YET_RECRUITING","sponsor":"St. Joseph's Healthcare Hamilton","startDate":"2025-09-07","conditions":"Respiratory Insufficiency","enrollment":300},{"nctId":"NCT00532155","phase":"PHASE3","title":"A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer","status":"COMPLETED","sponsor":"Sanofi","startDate":"2007-09","conditions":"Carcinoma, Non Small Cell Lung","enrollment":913},{"nctId":"NCT05664191","phase":"PHASE2","title":"Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-10-13","conditions":"Sub-arachnoid Haemorrhage","enrollment":30},{"nctId":"NCT06834321","phase":"PHASE2","title":"Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer","status":"RECRUITING","sponsor":"baotai Liang","startDate":"2025-03-19","conditions":"Prostate CA","enrollment":96},{"nctId":"NCT06486805","phase":"PHASE4","title":"N-Acetyl Cysteine Effect on Liver Function After Mitral Valve Replacement","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2024-06-30","conditions":"Oxidative Stress, Liver Dysfunction","enrollment":54},{"nctId":"NCT05464940","phase":"NA","title":"Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction","status":"NOT_YET_RECRUITING","sponsor":"Kansas City Heart Rhythm Research Foundation","startDate":"2025-09","conditions":"Atrial Fibrillation","enrollment":100},{"nctId":"NCT03008005","phase":"PHASE4","title":"Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2017-06-01","conditions":"PostTraumatic Stress Disorder","enrollment":46},{"nctId":"NCT05614115","phase":"PHASE1","title":"Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD","status":"COMPLETED","sponsor":"University of Utah","startDate":"2023-03-21","conditions":"End-stage Kidney Disease, Kidney Disease, Chronic, Dialysis","enrollment":62},{"nctId":"NCT03938389","phase":"PHASE4","title":"The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University","startDate":"2020-02-25","conditions":"PreDiabetes, Impaired Glucose Tolerance, Obesity","enrollment":90},{"nctId":"NCT05895747","phase":"PHASE2","title":"5-HTP and Creatine for Depression R33 Phase","status":"RECRUITING","sponsor":"University of Utah","startDate":"2023-09-28","conditions":"Major Depressive Disorder","enrollment":106},{"nctId":"NCT06471647","phase":"EARLY_PHASE1","title":"Effects of Drugs on Stress Memories","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2024-07-01","conditions":"Delta-9-tetrahydrocannabinol (THC), Stress","enrollment":36},{"nctId":"NCT07095049","phase":"PHASE1","title":"Safety, Tolerability, and Systemic Exposure of Apo-Si- K170A-C76 in Healthy Volunteers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Interna Therapeutics Ltd.","startDate":"2024-09-04","conditions":"SARS-CoV-2 (COVID-19) Infection","enrollment":56},{"nctId":"NCT06890039","phase":"PHASE2","title":"A-TANGO Phase 2 Study","status":"NOT_YET_RECRUITING","sponsor":"Yaqrit Ltd","startDate":"2025-09-01","conditions":"Acute-On-Chronic Liver Failure, Alcoholic Hepatitis, Liver Cirrhosis, Alcoholic","enrollment":78},{"nctId":"NCT01495806","phase":"PHASE4","title":"Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood","status":"COMPLETED","sponsor":"Medical University of Warsaw","startDate":"2010-01","conditions":"Functional Gastrointestinal Disorders","enrollment":89},{"nctId":"NCT06818851","phase":"PHASE4","title":"The Effects of Henagliflozin on Glucose Fluctuation and Immunosenescence in Type 2 Diabetes Patients on Insulin Therapy","status":"RECRUITING","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2025-07-14","conditions":"Diabetes Mellitus, Type 2","enrollment":64},{"nctId":"NCT03834506","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-05-02","conditions":"Prostatic Neoplasms","enrollment":1030},{"nctId":"NCT06912048","phase":"NA","title":"Understanding Individual Variability in Neuronal Signal Transmission to Target Organs in Health and Disease","status":"RECRUITING","sponsor":"University of Ulm","startDate":"2025-05-14","conditions":"Autonomic Function","enrollment":52},{"nctId":"NCT06675708","phase":"NA","title":"Effectiveness of Creatine on Pain, Fatigue, and Muscle Architectural Variables in Patients Witg Fibromyalgia.","status":"ENROLLING_BY_INVITATION","sponsor":"Camilo Jose Cela University","startDate":"2025-02-12","conditions":"Fibromyalgia","enrollment":80},{"nctId":"NCT03847467","phase":"PHASE1, PHASE2","title":"Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2019-09-20","conditions":"Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis","enrollment":116},{"nctId":"NCT06794723","phase":"PHASE2","title":"A Probiotic Based Intervention in Pregnancies Complicated by GDM","status":"NOT_YET_RECRUITING","sponsor":"Queen's University","startDate":"2025-10-01","conditions":"Gestational Diabetes Mellitus (GDM), Microbiome, Human","enrollment":173},{"nctId":"NCT04832009","phase":"EARLY_PHASE1","title":"Reversing Glucose and Lipid-mediated Vascular Dysfunction","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2022-05-09","conditions":"Blood Pressure, Hypertension","enrollment":46},{"nctId":"NCT04600921","phase":"PHASE3","title":"Ertugliflozin to Reduce Arrhythmic Burden in ICD/CRT patientS (ERASe-Trial) - a Phase III Study","status":"TERMINATED","sponsor":"Medical University of Graz","startDate":"2021-06-24","conditions":"Heart Failure With Reduced Ejection Fraction, Heart Failure With Mid Range Ejection Fraction, Implantable Cardioverter-Defibrillators","enrollment":55},{"nctId":"NCT05519644","phase":"NA","title":"Strategies to Augment Ketosis: Ketone Conferred Resiliency Against Sleep Restriction","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2023-06-20","conditions":"Sleep Deprivation","enrollment":60},{"nctId":"NCT06977659","phase":"PHASE1, PHASE2","title":"Early Norepinephrine in Trauma Patients With Hemorrhagic Shock","status":"ENROLLING_BY_INVITATION","sponsor":"Visarat Palitnonkiat","startDate":"2025-05-20","conditions":"Trauma, Multiple","enrollment":40},{"nctId":"NCT05624138","phase":"PHASE3","title":"The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy","status":"RECRUITING","sponsor":"Tanta University","startDate":"2022-11-09","conditions":"Neuropathy;Peripheral","enrollment":64},{"nctId":"NCT01746979","phase":"PHASE3","title":"Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma","status":"COMPLETED","sponsor":"ImmunoGenesis","startDate":"2012-12","conditions":"Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma","enrollment":693},{"nctId":"NCT04329624","phase":"PHASE3","title":"Effect Levosimendan Administration on Postoperative NT-proBNP in Cardiac Risk Patients","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2020-10-10","conditions":"Cardiovascular Risk Factor","enrollment":230},{"nctId":"NCT04264897","phase":"PHASE3","title":"Antecedent Metabolic Health and Metformin Aging Study","status":"COMPLETED","sponsor":"Oklahoma Medical Research Foundation","startDate":"2020-07-29","conditions":"Aging, Insulin Sensitivity, Chronic Disease","enrollment":101},{"nctId":"NCT02561000","phase":"PHASE2","title":"Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2016-05-27","conditions":"Arterial Occlusive Diseases, Coronary Artery Disease, Coronary Disease","enrollment":100},{"nctId":"NCT06920667","phase":"NA","title":"Effect of a Protein-Creatine-Omega3-Vitamin D Supplement on Glycemic Variability in Mexican Patients With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Héctor Iván Saldívar Cerón","startDate":"2025-06-01","conditions":"Type 2 Diabetes Mellitus","enrollment":40},{"nctId":"NCT06812221","phase":"PHASE1, PHASE2","title":"Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCI","status":"COMPLETED","sponsor":"Biomind Labs Inc.","startDate":"2024-12-15","conditions":"Mild Cognitive Impairment, Anxiety State, Depression Anxiety Disorder","enrollment":20},{"nctId":"NCT06896253","phase":"PHASE2","title":"Pulse Corticosteroids Or/and Immunoglobulins to Treat Fulminant Myocarditis","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-04","conditions":"Myocarditis Acute","enrollment":120},{"nctId":"NCT06173973","phase":"PHASE2, PHASE3","title":"Effects of Ketone Supplementation on Acute Alcohol Withdrawal","status":"ENROLLING_BY_INVITATION","sponsor":"University of Pennsylvania","startDate":"2024-03-11","conditions":"Alcohol Use Disorder, Alcohol Withdrawal, Alcohol Dependence","enrollment":50},{"nctId":"NCT03408613","phase":"NA","title":"Obstructive Sleep Apnea and Glucose Metabolism","status":"SUSPENDED","sponsor":"University of Missouri-Columbia","startDate":"2018-01-17","conditions":"Sleep Apnea, Glucose Metabolism Disorders","enrollment":80},{"nctId":"NCT03596788","phase":"NA","title":"Effects of Different Sports Supplements on Metabolism and Perceptual Responses During Distance Running","status":"TERMINATED","sponsor":"Old Dominion University","startDate":"2018-08-01","conditions":"Anomalies Gastrointestinal","enrollment":4},{"nctId":"NCT02980276","phase":"PHASE3","title":"RCT Metformin for Reduction of Gestational Diabetes Mellitus Effects","status":"COMPLETED","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2017-06-06","conditions":"Gestational Diabetes","enrollment":535},{"nctId":"NCT03478215","phase":"PHASE2","title":"Mesenchymal Stromal Cells in Living Donor Kidney Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2016-12","conditions":"Renal Transplantation, Mesenchymal Stem Cells","enrollment":24},{"nctId":"NCT03775109","phase":"PHASE2","title":"IL-1 Signal Inhibition in Alcoholic Hepatitis","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2019-02-12","conditions":"Alcoholic Hepatitis","enrollment":55},{"nctId":"NCT06816667","phase":"PHASE1, PHASE2","title":"Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety","status":"COMPLETED","sponsor":"Biomind Labs Inc.","startDate":"2024-10-21","conditions":"Healthy Volunteers","enrollment":40},{"nctId":"NCT06593769","phase":"NA","title":"Glycemic and Appetite Effects of a Pre-meal Whey-Protein Microgel","status":"COMPLETED","sponsor":"Société des Produits Nestlé (SPN)","startDate":"2024-10-09","conditions":"Glucose Metabolism, Appetite Regulation","enrollment":18},{"nctId":"NCT00740948","phase":"PHASE2, PHASE3","title":"Tolerance and Efficacy of Rituximab in Sjogren's Disease","status":"COMPLETED","sponsor":"University Hospital, Brest","startDate":"2008-03","conditions":"Sjogren's Disease","enrollment":122},{"nctId":"NCT05688111","phase":"NA","title":"Tranexamic Acid as an Intervention in Placenta Previa","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2022-12-10","conditions":"Interventional Drug in Placenta Previa","enrollment":146},{"nctId":"NCT04862234","phase":"PHASE4","title":"Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients","status":"TERMINATED","sponsor":"Emory University","startDate":"2021-08-06","conditions":"Hyperglycemia Stress","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo"],"phase":"phase_3","status":"active","brandName":"Glucose 5% (placebo)","genericName":"Glucose 5% (placebo)","companyName":"Hospices Civils de Lyon","companyId":"hospices-civils-de-lyon","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Glucose 5% solution serves as an inert placebo control with no active pharmacological mechanism. Used for Placebo control in phase 3 clinical trial (specific indication unknown).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}